Healthcare -
Biotechnology - NASDAQ - US
$ 16.5
0.671 %
$ 3.9 B
Market Cap
61.11
P/E
ADMA - SHORT-TERM DEBT
Short-term Debt ADMA - ADMA Biologics, Inc.
863 K
LAST VALUE
20.83%
2 YEAR CAGR
70.46%
5 YEAR CAGR
52.54%
10 YEAR CAGR